Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
72,119,556
-
Total 13F shares
-
12,246,779
-
Share change
-
-1,670,774
-
Total reported value
-
$23,953,554
-
Price per share
-
$1.96
-
Number of holders
-
15
-
Value change
-
-$3,111,706
-
Number of buys
-
6
-
Number of sells
-
6
Institutional Holders of IO Biotech, Inc. - Common (IOBT) as of Q2 2023
As of 30 Jun 2023,
IO Biotech, Inc. - Common (IOBT) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,246,779 shares.
The largest 10 holders included
Novo Holdings A/S, Vivo Capital, LLC, Avoro Capital Advisors LLC, BANK OF AMERICA CORP /DE/, Samsara BioCapital, LLC, PFM Health Sciences, LP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, and Aureus Asset Management, LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.